# Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis

> **NCT00543426** · PHASE4 · COMPLETED · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 200 (actual)

## Conditions studied

- Posthepatitic Cirrhosis

## Interventions

- **DRUG:** Fuzheng Huayu Tablets
- **DRUG:** sham Fuzheng Huayu Tablets (placebo)

## Key facts

- **NCT ID:** NCT00543426
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-05
- **Final completion:** 2009-06
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2013-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543426, "Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00543426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*